newsfilter
← Latest News
GlobeNewswire·

Psyence BioMed Announces Settlement of Shareholder Litigation

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company") today announced that it has entered into a settlement agreement to resolve a direct